Selected article for: "PCR screening and PDD case"
Author: Kistler, Amy L; Gancz, Ady; Clubb, Susan; Skewes-Cox, Peter; Fischer, Kael; Sorber, Katherine; Chiu, Charles Y; Lublin, Avishai; Mechani, Sara; Farnoushi, Yigal; Greninger, Alexander; Wen, Christopher C; Karlene, Scott B; Ganem, Don; DeRisi, Joseph L
Title: Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: Identification of a candidate etiologic agent
  • Document date: 2008_7_31
    • ID: 17qoax09_20
    Snippet: Because we applied stringent inclusion criteria for the above-described association analysis study, a number of ABV (+) and ABV (-) samples were excluded. From these materials, six additional ABV isolates were detected -5 derived from cases considered clinically suspicious and a sixth isolate derived from a confirmed PDD case for which only GI content and liver specimens were available. Additional PCR screening of a set of 12 PDD control crop bio.....
    Document: Because we applied stringent inclusion criteria for the above-described association analysis study, a number of ABV (+) and ABV (-) samples were excluded. From these materials, six additional ABV isolates were detected -5 derived from cases considered clinically suspicious and a sixth isolate derived from a confirmed PDD case for which only GI content and liver specimens were available. Additional PCR screening of a set of 12 PDD control crop biopsy specimens provided to us unblinded again yielded solely ABV PCR (-) and GAPDH (+) results. These samples were excluded from the association analysis because we knew their clinical status prior to screening. We note that inclusion of these samples in statistical analyses would not diminish the association of ABV with known or suspected PDD.

    Search related documents:
    Co phrase search for related documents
    • ABV association and clinical status: 1
    • ABV association and PCR screening: 1, 2, 3
    • ABV association and PDD case: 1, 2
    • ABV association and PDD control: 1, 2
    • ABV number and PCR screening: 1
    • ABV number and PDD case: 1
    • analysis study and association analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • analysis study and association analysis study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • analysis study and clinical status: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • analysis study and inclusion criterion: 1, 2
    • analysis study and PCR screening: 1, 2, 3, 4, 5, 6, 7
    • association analysis and clinical status: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • association analysis and GI content: 1
    • association analysis and PCR screening: 1, 2
    • association analysis and PDD control: 1
    • clinical status and PCR screening: 1, 2, 3
    • clinical status and PDD case: 1
    • clinical status and PDD control: 1